NSF International Acquires David Begg ...( Acquisition Provides Expanded Servi...)

Acquisition Provides Expanded Services to the Pharmaceutical and Biotech

Industries

ANN ARBOR, Mich. and KIRKBYMOORSIDE, England, Sept. 10 /PRNewswire- USNewswire/ -- NSF International (NSF), an independent, not-for-profit organization committed to providing public health protection, today announced the acquisition of David Begg Associates (DBA), an organization that provides professional, high-quality training and auditing solutions to the pharmaceutical and healthcare industries.

(Logo: http://www.newscom.com/cgi-bin/prnh/20070816/DCTH039LOGO )

Together, both NSF and DBA will provide unmatched technical services that will support the testing and training needs of pharmaceutical and biotech companies. Key stakeholders who will benefit from this acquisition include manufacturers of pharmaceuticals, retailers and consumers.

"In fulfilling one of our key strategic objectives, we are delighted to become part of NSF International, an organization like ourselves, founded on and developed through sound ethical principles and core values," said Bob Pietrowski, Managing Partner at DBA. "We are confident that this partnership will bring significant benefits to both parties, and we look forward to the prospect of bringing our unparalleled GMP and regulatory training and auditing expertise to a broader international client base."

Established in 1986, DBA has an international reputation in the field of pharmaceutical quality management, regulatory compliance and training. DBA's leading position in the United Kingdom will give NSF an expanded presence in the European market, while providing additional training services to meet the unique needs of clients worldwide.

"This is an outstanding opportunity for both organizations to expand our global biotech services," said Kevan P. Lawlor, NSF CEO and President. "Combining DB
'/>"/>